DAYTRANA Side Effects

6075404-4 | Anterior Chamber Cleavage Syndrome, Condition Aggravated, Off Label Use, Somnolence
on Jan 27, 2009 Male patient from UNITED STATES , 15 years of age, weighting 110.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: anterior chamber cleavage syndrome, condition aggravated, off label use, somnolence. Daytrana dosage: 20 Mg, 1x/day:qd, Oral. During the same period patient was treated with EYE DROPS (View Eye Drops Review and Eye Drops Label ).

6059687-2 | Product Quality Issue, Salmonellosis
Patient was taking Daytrana (View Usage). Patient had the following side effects: product quality issue, salmonellosis on Jan 23, 2009 from UNITED STATES Additional patient health information: Male patient , child 6 years of age, weighting 42.99 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with NUTROPIN (View Nutropin Review and Nutropin Label ). Patient was hospitalized.

6037717-1 | Abdominal Discomfort, Asthenia, Blood Bicarbonate Increased, Dehydration, Delirium, Dizziness, Heart Rate Decreased, Hypotension, Incoherent
Adverse event was reported on Dec 30, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 40 Mg (two 2mg Patches), 1x/day;qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder, insomnia and. Location: UNITED STATES , 14 years of age, weighting 130.1 lb, After Daytrana was administered, patient had the following side effects: abdominal discomfort, asthenia, blood bicarbonate increased, dehydration, delirium, dizziness (What is dizziness?), heart rate decreased, hypotension, incoherent. During the same period patient was treated with STRATTERA (40 Mg, As Req'd, Oral) (View Strattera Review and Strattera Label ).

6036407-9 | Thrombocytopenia
on Dec 30, 2008 Male patient from UNITED STATES , child 7 years of age, weighting 61.73 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Daytrana dosage: 15 Mg, 1x/day:qd, Transdermal; 10 Mg, 1x/day:qd, Transdermal. Patient was hospitalized.


6026622-2 | Dehydration, Delirium, Dizziness, Heart Rate Decreased, Hypotension, Insomnia, Loss Of Consciousness, Off Label Use, Overdose
on Dec 23, 2008 Male patient from UNITED STATES , 14 years of age, weighting 130.1 lb, was diagnosed with attention deficit/hyperactivity disorder, insomnia and was treated with Daytrana (View Usage). Patient had the following side effects: dehydration, delirium, dizziness (What is dizziness?), heart rate decreased, hypotension, insomnia, loss of consciousness, off label use, overdose. Daytrana dosage: 40 Mg (two 20mg Patches), 1x/day:qd, Transdermal. During the same period patient was treated with STRATTERA (40 Mg, As Req'd, Oral) (View Strattera Review and Strattera Label ).

6016769-9 | Application Site Rash, Product Quality Issue, Scarlet Fever, Weight Decreased
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site rash, product quality issue, scarlet fever, weight decreased on Dec 02, 2008 from UNITED STATES Additional patient health information: Female patient , child 11 years of age, weighting 104.9 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), NASONEX (View Nasonex Review and Nasonex Label ), PEPCID (View Pepcid Review and Pepcid Label ).

6016219-2 | Application Site Burn, Application Site Discolouration, Application Site Dryness, Application Site Scab, Application Site Swelling, Asthma
Adverse event was reported on Dec 03, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 20 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 8 years of age, weighting 61.95 lb, Patient experienced the following unwanted or unexpected effects: application site burn, application site discolouration, application site dryness, application site scab, application site swelling, asthma (What is asthma?). During the same period patient was treated with SINGULAIR /01262601/ (MONTELUKAST) (View Singulair /01262601/ (montelukast) Review and Singulair /01262601/ (montelukast) Label ), ALBUTEROL /0013950/ (SALBUTAMOL) INHALATION GAS (View Albuterol /0013950/ (salbutamol) Inhalation Gas Review and Albuterol /0013950/ (salbutamol) Inhalation Gas Label ).

5999094-1 | Ear Infection, Insomnia, Off Label Use, Pneumonia, Product Quality Issue
on Nov 26, 2008 Female patient from UNITED STATES , child 5 years of age, weighting 46.08 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: ear infection (What is ear infection?), insomnia, off label use, pneumonia (What is pneumonia?), product quality issue. Daytrana dosage: 10 Mg, 1x/day;qd, Transdermal. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), ZOVINOX (View Zovinox Review and Zovinox Label ), CLARITIN (View Claritin Review and Claritin Label ).

5992814-1 | Convulsion
on Aug 25, 2008 Male patient from UNITED STATES , child 9 years of age, weighting 104.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: convulsion. Daytrana dosage: 15 Mg, 1x/day:qd, Transdermal.

5989366-9 | Dehydration, Delirium, Dizziness, Hypotension, Insomnia, Off Label Use, Overdose, Syncope
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, delirium, dizziness (What is dizziness?), hypotension, insomnia, off label use, overdose, syncope on Nov 19, 2008 from UNITED STATES Additional patient health information: Male patient , 14 years of age, weighting 119.9 lb, was diagnosed with attention deficit/hyperactivity disorder, insomnia and. Daytrana dosage: 40 Mg (two 20mg Patches), 1x/day:qd, Transdermal. During the same period patient was treated with STRATTERA (40 Mg, As Req'd, Oral) (View Strattera Review and Strattera Label ).

5988188-2 | Dehydration, Delirium, Dizziness, Hypotension, Insomnia, Off Label Use, Syncope
Adverse event was reported on Nov 19, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 40 Mg (two 20mg Patches), 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder, insomnia and. Location: UNITED STATES , 14 years of age, weighting 119.9 lb, Patient had the following side effects: dehydration, delirium, dizziness (What is dizziness?), hypotension, insomnia, off label use, syncope. During the same period patient was treated with STRATTERA (40 Mg, As Req'd, Oral) (View Strattera Review and Strattera Label ).

5985161-5 | Application Site Erosion, Application Site Erythema, Application Site Pain, Application Site Swelling, Off Label Use, Umbilical Hernia
on Nov 19, 2008 Female patient from UNITED STATES , 20 years of age, weighting 157.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erosion, application site erythema, application site pain, application site swelling, off label use, umbilical hernia. Daytrana dosage: 30 Mg, 1x.day:qd, Transdermal. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), XANAX (View Xanax Review and Xanax Label ).

5973857-0 | Blood Pressure Diastolic Decreased, Chest Pain, Heart Rate Increased, Heart Sounds Abnormal, Sinus Arrhythmia, Syncope
on Nov 13, 2008 Female patient from UNITED STATES , child 6 years of age, weighting 43.43 lb, was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic decreased, chest pain (What is chest pain?), heart rate increased, heart sounds abnormal, sinus arrhythmia, syncope. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal.

5964120-2 | Application Site Discolouration, Skin Depigmentation
Patient was taking Daytrana (View Usage). Patient had the following side effects: application site discolouration, skin depigmentation on Nov 21, 2008 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 100.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: .

5960954-9 | Addison's Disease, Blood Sodium Decreased, Diarrhoea, Nausea
Adverse event was reported on Nov 06, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 1xday,qd; Transdermal) . Location: UNITED STATES , child 8 years of age, After Daytrana was administered, patient had the following side effects: addison's disease (What is addison's disease?), blood sodium decreased, diarrhoea, nausea (What is nausea?). Patient was hospitalized.

5955994-X | Convulsion, Encephalitis Viral
on Oct 28, 2008 Male patient from UNITED STATES , child 11 years of age, weighting 67.90 lb, was diagnosed with disturbance in attention, psychomotor hyperactivity and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, encephalitis viral. Daytrana dosage: 15 Mg, 1x/day: Qd, Transdermal; 10 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with ZOLOFT /0101140/ (SERTRALINE) (View Zoloft /0101140/ (sertraline) Review and Zoloft /0101140/ (sertraline) Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PROBIOTICS (BACTERIA NOS) (View Probiotics (bacteria Nos) Review and Probiotics (bacteria Nos) Label ), VITAMIN C /00008001/ (ASCORBIC ACID) (View Vitamin C /00008001/ (ascorbic Acid) Review and Vitamin C /00008001/ (ascorbic Acid) Label ). Patient was hospitalized.

5955993-8 | Impulsive Behaviour, Suicide Attempt, Treatment Noncompliance
on Nov 05, 2008 Male patient from UNITED STATES , child 6 years of age, weighting 59.97 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: impulsive behaviour, suicide attempt, treatment noncompliance. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal; 10 Mg, 1x/day:qd, Transdermal.

5955992-6 | Application Site Urticaria, Convulsion, Encephalitis Viral
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site urticaria, convulsion, encephalitis viral on Oct 28, 2008 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 67.90 lb, was diagnosed with disturbance in attention, psychomotor hyperactivity and. Daytrana dosage: 15 Mg, 1x/day:qd; 10 Mg, 1x/day, Transdermal. During the same period patient was treated with ZOLOFT /01022401/ (SERTRALINE) (View Zoloft /01022401/ (sertraline) Review and Zoloft /01022401/ (sertraline) Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PROBIOTICS (BACTERIA NOS) (View Probiotics (bacteria Nos) Review and Probiotics (bacteria Nos) Label ), VITAMIN C /00008001/(ASCORBIC ACID) (View Vitamin C /00008001/(ascorbic Acid) Review and Vitamin C /00008001/(ascorbic Acid) Label ). Patient was hospitalized.

5944321-X | Impulsive Behaviour, Suicide Attempt
Adverse event was reported on Oct 21, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 20 Mg, 1x/day:qd, Transdermal, 10 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 6 years of age, weighting 59.97 lb, Patient experienced the following unwanted or unexpected effects: impulsive behaviour, suicide attempt.

5939751-6 | Asthenia, Dizziness, Fall, Staring
on Oct 30, 2008 Male patient from UNITED STATES , weighting 76.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: asthenia, dizziness (What is dizziness?), fall (What is fall?), staring. Daytrana dosage: 15 Mg Patch 1 Daily. During the same period patient was treated with TRAZADONE 50MG PLIVA (50mg 1 @ Bedtime) (View Trazadone 50mg Pliva Review and Trazadone 50mg Pliva Label ).

5919026-1 | Heat Stroke
on Oct 14, 2008 Male patient from UNITED STATES , 13 years of age, weighting 164.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: heat stroke. Daytrana dosage: 30mg 1x Day Transdermal. Patient was hospitalized and became disabled.

5908922-7 | Chest Pain, Loss Of Consciousness, Syncope
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), loss of consciousness, syncope on Sep 15, 2008 from UNITED STATES Additional patient health information: Female patient , child 6 years of age, weighting 43.43 lb, . Daytrana dosage: 10 Mg, 1x/day;qd, Transdermal.

5906800-0 | Feeling Abnormal, Off Label Use
Adverse event was reported on Sep 12, 2008 by a Female patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1x/day:qd, Transdermal) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 44 years of age, weighting 112.9 lb, Patient had the following side effects: feeling abnormal, off label use. During the same period patient was treated with PRILOSEC /00661201/(OMEPRAZOLE) (View Prilosec /00661201/(omeprazole) Review and Prilosec /00661201/(omeprazole) Label ), REGLAN (View Reglan Review and Reglan Label ), CELEXA (View Celexa Review and Celexa Label ), BUSPAR(BUSIPRONE HYDROCHLORIDE) (View Buspar(busiprone Hydrochloride) Review and Buspar(busiprone Hydrochloride) Label ), FIORICET (View Fioricet Review and Fioricet Label ). Patient was hospitalized.

5905446-8 | Application Site Rash
on Oct 01, 2008 Female patient from UNITED STATES , weighting 44.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site rash. Daytrana dosage: 20mg Qd Topical.

5879860-3 | Pruritus, Rash, Urticaria
on Sep 11, 2008 Male patient from UNITED STATES , 13 years of age, weighting 120.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?), urticaria. Daytrana dosage: 20mg.

5877445-6 | Chest Pain, Loss Of Consciousness
Patient was taking Daytrana (View Usage). Patient had the following side effects: chest pain (What is chest pain?), loss of consciousness on Aug 26, 2008 from UNITED STATES Additional patient health information: Female patient , child 6 years of age, . Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal.

5871724-4 | Application Site Pruritus, Application Site Urticaria, Dermatitis Contact
Adverse event was reported on Sep 04, 2008 by a Female patient taking Daytrana (View Usage) (Dosage: 30's - 10mg Apply 1 Patch Daily Ad Directed) was diagnosed with disturbance in attention and. Location: UNITED STATES , 55 years of age, After Daytrana was administered, patient had the following side effects: application site pruritus, application site urticaria, dermatitis contact.

5860722-2 | Application Site Erythema, Dyskinesia, Dysphagia, Dysphemia, Muscle Spasms, Palpitations, Peripheral Coldness, Psychotic Disorder
on Aug 11, 2008 Male patient from UNITED STATES , child 10 years of age, weighting 65.04 lb, was diagnosed with attention deficit/hyperactivity disorder, anger, restlessness and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, dyskinesia, dysphagia, dysphemia, muscle spasms, palpitations, peripheral coldness, psychotic disorder (What is psychotic disorder?). Daytrana dosage: 30 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with RISPERDAL (0.5 Mg (1/2 Tab), 1x/day:qd In Am, Oral) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5842689-6 | Application Site Urticaria, Convulsion, Encephalitis Viral, Off Label Use
on Jul 24, 2008 Male patient from UNITED STATES , child 11 years of age, weighting 67.90 lb, was diagnosed with autism (What is autism?) and was treated with Daytrana (View Usage). Patient had the following side effects: application site urticaria, convulsion, encephalitis viral, off label use. Daytrana dosage: 15 Mg, 1x/day:qd Transdermal; 10 Mg, 1x/day;qd, Transdermal. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ), PROBIOTICS (BACTERIA NOS) (View Probiotics (bacteria Nos) Review and Probiotics (bacteria Nos) Label ), VITAMIN C /00008001/ (ASCORBIC ACID) (View Vitamin C /00008001/ (ascorbic Acid) Review and Vitamin C /00008001/ (ascorbic Acid) Label ). Patient was hospitalized.

5834127-4 | Abnormal Behaviour, Disturbance In Attention, Intentional Self-injury, Pyromania
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: abnormal behaviour, disturbance in attention, intentional self-injury, pyromania on Jul 22, 2008 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, weighting 85.98 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 15 Mg, 1x/day:qd, Transdermal.

5823919-3 | Application Site Erythema, Dyskinesia, Dysphagia, Dysphemia, Muscle Spasms, Palpitations, Peripheral Coldness, Psychotic Disorder
Adverse event was reported on Jul 09, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1x/day: Qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 10 years of age, weighting 65.04 lb, Patient experienced the following unwanted or unexpected effects: application site erythema, dyskinesia, dysphagia, dysphemia, muscle spasms, palpitations, peripheral coldness, psychotic disorder (What is psychotic disorder?). During the same period patient was treated with RISPERDAL (0.5 Mg (1/2 Tab), 1x/day: Qd In Am, Oral; 0.5 Mg, 1x/day:qd At Bedtime, Oral) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

5796279-4 | Ventricular Septal Defect
on Jun 12, 2008 Female patient from UNITED STATES , weighting 6.17 lb, was treated with Daytrana (View Usage). Patient had the following side effects: ventricular septal defect. Daytrana dosage: .

5788518-0 | Application Site Erythema, Application Site Irritation, Application Site Pruritus
on Jun 25, 2008 Male patient from UNITED STATES , weighting 270.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erythema, application site irritation, application site pruritus. Daytrana dosage: 30 Mg Patch Qam. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ), ABILIFY (View Abilify Review and Abilify Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), NEXIUM (View Nexium Review and Nexium Label ).

5774690-5 | Pruritus, Rash
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?) on Jun 16, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 189.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 10mg (two Patches) Qam Patch.

5765788-6 | Convulsion
Adverse event was reported on Mar 31, 2008 by a Female patient taking Daytrana (View Usage) (Dosage: 30 Mg, 1x/day:qd, Transdermal ; 20 Mg, 1x/day:qd, Transdermal) . Location: UNITED STATES , child 8 years of age, Patient had the following side effects: convulsion. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ).

5765786-2 | Agitation, Hallucination, Visual, Heart Rate Increased, Hypersensitivity, Lethargy, Psychomotor Hyperactivity
on Mar 18, 2008 Male patient from UNITED STATES , child 7 years of age, weighting 52.91 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: agitation, hallucination, visual, heart rate increased, hypersensitivity, lethargy, psychomotor hyperactivity. Daytrana dosage: See Image. During the same period patient was treated with SINGULAIR (View Singulair Review and Singulair Label ).

5765782-5 | Application Site Erythema, Application Site Irritation, Application Site Pruritus, Convulsion, Lethargy, Mood Altered
on Mar 18, 2008 Female patient from UNITED STATES , child 10 years of age, weighting 59.97 lb, was diagnosed with attention deficit/hyperactivity disorder, bipolar disorder (What is bipolar disorder?) and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, application site irritation, application site pruritus, convulsion, lethargy, mood altered. Daytrana dosage: 30 Mg, 1x/day:qd, Transdermal ; 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with SEROQUEL (25 Mg, 2x/day:bid, Oral ; 25 Mg, 1x/day:qd In Pm, Oral) (View Seroquel Review and Seroquel Label ), FOCALIN (5 Mg, 1x/day:qd, Oral) (View Focalin Review and Focalin Label ).

5765772-2 | Abnormal Behaviour, Convulsion
Patient was taking Daytrana (View Usage). Patient had the following side effects: abnormal behaviour, convulsion on Feb 22, 2008 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, was diagnosed with prophylaxis and. Daytrana dosage: 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with TRILEPTAL (View Trileptal Review and Trileptal Label ).

5713320-5 | Decreased Appetite, Educational Problem, Growth Accelerated, Increased Appetite, Pelvi-ureteric Obstruction
Adverse event was reported on Apr 08, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 10 Mg, 1x/day;qd, Transdermal; 15 Mg, 1x/day;qd, Transdermal; 20 Mg, 1x/day, Qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 10 years of age, weighting 69.89 lb, After Daytrana was administered, patient had the following side effects: decreased appetite, educational problem, growth accelerated, increased appetite, pelvi-ureteric obstruction. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

5680835-8 | Decreased Appetite, Disturbance In Attention, Educational Problem, Growth Accelerated, Increased Appetite, Pelvi-ureteric Obstruction
on Mar 14, 2008 Male patient from UNITED STATES , child 10 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, disturbance in attention, educational problem, growth accelerated, increased appetite, pelvi-ureteric obstruction. Daytrana dosage: 10 Mg, 1x/day:qd, Transdermal; 15 Mg, 1x/day:qd, Transdermal; 20 Mg, 1x/day:qd, Transdermal. During the same period patient was treated with LEXAPRO (View Lexapro Review and Lexapro Label ). Patient was hospitalized.

5679036-9 | Abnormal Behaviour, Aggression, Agitation, Application Site Rash, Mood Swings, Off Label Use
on Mar 10, 2008 Male patient from UNITED STATES , 13 years of age, weighting 95.02 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: abnormal behaviour, aggression, agitation, application site rash, mood swings, off label use. Daytrana dosage: 15 Mg, 1x/day: Qd, Transdermal.

5672000-5 | Accidental Exposure
Patient was taking Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: accidental exposure on Mar 18, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 150.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: Od Skin Patch.

5670945-3 | Application Site Erythema, Application Site Rash, Pneumonia, Tic
Adverse event was reported on Mar 04, 2008 by a Female patient taking Daytrana (View Usage) (Dosage: 20 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 11 years of age, weighting 69.89 lb, Patient experienced the following unwanted or unexpected effects: application site erythema, application site rash, pneumonia (What is pneumonia?), tic (What is tic?). During the same period patient was treated with ADDERALL XR (AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE (View Adderall Xr (amfetamine Aspartate, Amfetamine Sulfate, Dexamfetamine Review and Adderall Xr (amfetamine Aspartate, Amfetamine Sulfate, Dexamfetamine Label ).

5653738-2 | Application Site Excoriation, Application Site Irritation, Application Site Scab, Dermatitis Contact
on Nov 19, 2007 Male patient from UNITED STATES , child 12 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient had the following side effects: application site excoriation, application site irritation, application site scab, dermatitis contact. Daytrana dosage: 20 Mg, 1x/day:qd; 20 Mg, 1x/day:qd, Transdermal.

5633490-7 | Abnormal Behaviour, Aggression, Device Failure, Self Injurious Behaviour, Suicidal Ideation
on Feb 07, 2008 Female patient from UNITED STATES , child 9 years of age, weighting 130.1 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: abnormal behaviour, aggression, device failure, self injurious behaviour, suicidal ideation. Daytrana dosage: 20 Mg, 1x/day: Qd, Transdermal; 15 Mg, 1x/day: Qd, Transdermal; 10 Mg, 1x/day: Qd, Transdermal. During the same period patient was treated with SINGULAIR /01362601/ (MONTELUKAST) (View Singulair /01362601/ (montelukast) Review and Singulair /01362601/ (montelukast) Label ), FLOVENT (View Flovent Review and Flovent Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), PROVENTIL /00139501/ (SALBUTAMOL) (View Proventil /00139501/ (salbutamol) Review and Proventil /00139501/ (salbutamol) Label ).

5616256-3 | Ankle Fracture, Clavicle Fracture, Osteomyelitis
Patient was taking Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: ankle fracture, clavicle fracture, osteomyelitis on Jan 25, 2008 from UNITED STATES Additional patient health information: Female patient , child 10 years of age, weighting 76.94 lb, was diagnosed with attention deficit/hyperactivity disorder and. Daytrana dosage: 15 Mg, 1x/day:qd, Transdermal.

5610924-5 | Growth Retardation, Weight Gain Poor
Adverse event was reported on Jan 14, 2008 by a Male patient taking Daytrana (View Usage) (Dosage: 10 Mg, 1x/day:qd, Transdermal) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 12 years of age, weighting 57.98 lb, Patient had the following side effects: growth retardation, weight gain poor.

5586209-2 | Application Site Erythema, Decreased Appetite, Disturbance In Attention, Hunger, Increased Appetite, Mania
on Dec 26, 2007 Male patient from UNITED STATES , child 8 years of age, weighting 61.95 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). After Daytrana was administered, patient had the following side effects: application site erythema, decreased appetite, disturbance in attention, hunger, increased appetite, mania. Daytrana dosage: See Image. During the same period patient was treated with ZOLOFT (50 Mg, 1x/day; Qd, Oral; 75 Mg Daily, Oral) (View Zoloft Review and Zoloft Label ).

5554858-3 | Application Site Erythema, Application Site Irritation, Application Site Pruritus, Application Site Vesicles, Off Label Use, Sepsis
on Nov 26, 2007 Male patient from UNITED STATES , 14 years of age, weighting 85.98 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, application site irritation, application site pruritus, application site vesicles, off label use, sepsis (What is sepsis?). Daytrana dosage: 10 Mg, 1x Day: Qd, Transdermal. Patient was hospitalized.

5527080-4 | Decreased Appetite, Weight Gain Poor
Patient was taking Daytrana (View Usage). Patient had the following side effects: decreased appetite, weight gain poor on Nov 09, 2007 from UNITED STATES Additional patient health information: Male patient , child 11 years of age, . Daytrana dosage: Transdermal. During the same period patient was treated with ADDERALL XR(AMPHENTAMINE ASPARTATE, AMPHETAMINE SULFATE, DEXTROAMPHETA (View Adderall Xr(amphentamine Aspartate, Amphetamine Sulfate, Dextroampheta Review and Adderall Xr(amphentamine Aspartate, Amphetamine Sulfate, Dextroampheta Label ).